$Recursion Pharmaceuticals, In-To The Moon - Tiger Brokers Online Investing Community - To The Moon

$Recursion Pharmaceuticals, Inc.(RXRX)$

Developed in collaboration with Nvidia, BioHive-2 ranks No. 35 on the TOP500 list of the world’s most powerful supercomputers.

BioHive-2 operates four times faster than its predecessor, BioHive-1, and consists of an NVIDIA DGX SuperPOD AI supercomputer, powered by 63 DGX H100 systems with a total of 504 NVIDIA H100 Tensor Core GPUs interconnected by NVIDIA Quantum-2 InfiniBand networking.

With BioHive-2, Recursion plans to accelerate its AI-driven drug discovery processes. The company has generated and aggregated one of the largest biological and chemical datasets globally, which is used to train new AI models.

The increased computational power of BioHive-2 allows Recursion to train larger and more generalizable foundation models and AI agents more efficiently. This advancement supports the company’s efforts to industrialize drug discovery.

Sources: https://www.biopharmatrend.com/post/800-recursion-unveils-biohive-2-fastest-pharma-owned-supercomputer/

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":387893160624400,"tweetId":"387893160624400","gmtCreate":1735730923452,"gmtModify":1735731304398,"author":{"id":3576143479038940,"idStr":"3576143479038940","authorId":3576143479038940,"authorIdStr":"3576143479038940","name":"Mike Yong","avatar":"https://community-static.tradeup.com/news/af67eb1674939c91d407718f5b29ebea","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.23","exceedPercentage":"93.05%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":12,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/RXRX\">$Recursion Pharmaceuticals, Inc.(RXRX)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;\n<p><br></p>\n<p>Developed in collaboration with Nvidia, BioHive-2 ranks No. 35 on the TOP500 list of the world’s most powerful supercomputers.</p>\n<p>BioHive-2 operates four times faster than its predecessor, BioHive-1, and consists of an NVIDIA DGX SuperPOD AI supercomputer, powered by 63 DGX H100 systems with a total of 504 NVIDIA H100 Tensor Core GPUs interconnected by NVIDIA Quantum-2 InfiniBand networking.</p>\n<p>With BioHive-2, Recursion plans to accelerate its AI-driven drug discovery processes. The company has generated and aggregated one of the largest biological and chemical datasets globally, which is used to train new AI models.</p>\n<p>The increased computational power of BioHive-2 allows Recursion to train larger and more generalizable foundation models and AI agents more efficiently. This advancement supports the company’s efforts to industrialize drug discovery.</p>\n<p>Sources: https://www.biopharmatrend.com/post/800-recursion-unveils-biohive-2-fastest-pharma-owned-supercomputer/</p></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/RXRX\">$Recursion Pharmaceuticals, Inc.(RXRX)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;\n<p><br></p>\n<p>Developed in collaboration with Nvidia, BioHive-2 ranks No. 35 on the TOP500 list of the world’s most powerful supercomputers.</p>\n<p>BioHive-2 operates four times faster than its predecessor, BioHive-1, and consists of an NVIDIA DGX SuperPOD AI supercomputer, powered by 63 DGX H100 systems with a total of 504 NVIDIA H100 Tensor Core GPUs interconnected by NVIDIA Quantum-2 InfiniBand networking.</p>\n<p>With BioHive-2, Recursion plans to accelerate its AI-driven drug discovery processes. The company has generated and aggregated one of the largest biological and chemical datasets globally, which is used to train new AI models.</p>\n<p>The increased computational power of BioHive-2 allows Recursion to train larger and more generalizable foundation models and AI agents more efficiently. This advancement supports the company’s efforts to industrialize drug discovery.</p>\n<p>Sources: https://www.biopharmatrend.com/post/800-recursion-unveils-biohive-2-fastest-pharma-owned-supercomputer/</p></body></html>","text":"$Recursion Pharmaceuticals, Inc.(RXRX)$ Developed in collaboration with Nvidia, BioHive-2 ranks No. 35 on the TOP500 list of the world’s most powerful supercomputers. BioHive-2 operates four times faster than its predecessor, BioHive-1, and consists of an NVIDIA DGX SuperPOD AI supercomputer, powered by 63 DGX H100 systems with a total of 504 NVIDIA H100 Tensor Core GPUs interconnected by NVIDIA Quantum-2 InfiniBand networking. With BioHive-2, Recursion plans to accelerate its AI-driven drug discovery processes. The company has generated and aggregated one of the largest biological and chemical datasets globally, which is used to train new AI models. The increased computational power of BioHive-2 allows Recursion to train larger and more generalizable foundation models and AI agents more efficiently. This advancement supports the company’s efforts to industrialize drug discovery. Sources: https://www.biopharmatrend.com/post/800-recursion-unveils-biohive-2-fastest-pharma-owned-supercomputer/","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/387893160624400","repostId":0,"isVote":1,"tweetType":1,"viewCount":717,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["RXRX"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":877,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/387893160624400"}